{"schema_version":"1","generated_at":"2026-11-04T20:02:24.581Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ardaman-shergill","json_url":"https://www.findmykol.com/kol/ardaman-shergill/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ardaman-shergill","name":"Ardaman Shergill","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Alliance for Clinical Trials in Oncology","institution_url":"https://www.findmykol.com/institution/alliance-for-clinical-trials-in-oncology","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1992948152","orcid":"0000-0002-8244-2704","openalex":"A5079795657"},"summary":"Ardaman Shergill is an Oncology physician affiliated with Alliance for Clinical Trials in Oncology. OpenAlex indexes 166 publications with 4,175 citations (h-index 21); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":166,"cited_by_count":4175,"h_index":21,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05564403","title":"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT05564403","trial_url":"https://www.findmykol.com/trial/NCT05564403"},{"nct":"NCT05200442","title":"A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer","phase":"PHASE1/PHASE2","status":"SUSPENDED","role":"Overall official","sponsor":"University of Chicago","source_url":"https://clinicaltrials.gov/study/NCT05200442","trial_url":"https://www.findmykol.com/trial/NCT05200442"},{"nct":"NCT04107077","title":"Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Chicago","source_url":"https://clinicaltrials.gov/study/NCT04107077","trial_url":"https://www.findmykol.com/trial/NCT04107077"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":38,"shown":3,"withheld":35,"rows":[{"payer":"AbbVie","program_year":2025,"amount_usd":73355.16,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992948152"},{"payer":"GSK","program_year":2025,"amount_usd":60737,"payment_count":16,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992948152"},{"payer":"Eli Lilly","program_year":2025,"amount_usd":38758,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992948152"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992948152","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer","year":2026,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2507874","status":"verified"},{"title":"Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.17_suppl.lba1","status":"verified"},{"title":"Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases","year":2025,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-025-17363-0","status":"verified"},{"title":"Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.lba14","status":"verified"},{"title":"Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib","year":2025,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2025.5144","status":"verified"}],"source":"works"},"contact":{"address_1":"5841 S MARYLAND AVE","city":"Chicago","state":"IL","zip":"606371443","phone":"888-824-0200","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1992948152","source":"identity"},"similar":[{"name":"Olwen Hahn","slug":"olwen-hahn","institution":"Alliance for Clinical Trials in Oncology","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/olwen-hahn","json_url":"https://www.findmykol.com/kol/olwen-hahn/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":35,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-10-24","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}